Cargando…
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299946/ https://www.ncbi.nlm.nih.gov/pubmed/37393625 http://dx.doi.org/10.1016/j.thromres.2023.06.025 |
_version_ | 1785064479358189568 |
---|---|
author | Kleebayoon, Amnuay Wiwanitkit, Viroj |
author_facet | Kleebayoon, Amnuay Wiwanitkit, Viroj |
author_sort | Kleebayoon, Amnuay |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10299946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102999462023-06-28 Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence Kleebayoon, Amnuay Wiwanitkit, Viroj Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2023-06-28 /pmc/articles/PMC10299946/ /pubmed/37393625 http://dx.doi.org/10.1016/j.thromres.2023.06.025 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editors-in-Chief Kleebayoon, Amnuay Wiwanitkit, Viroj Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence |
title | Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence |
title_full | Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence |
title_fullStr | Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence |
title_full_unstemmed | Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence |
title_short | Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence |
title_sort | major cardiovascular events after covid-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: correspondence |
topic | Letter to the Editors-in-Chief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299946/ https://www.ncbi.nlm.nih.gov/pubmed/37393625 http://dx.doi.org/10.1016/j.thromres.2023.06.025 |
work_keys_str_mv | AT kleebayoonamnuay majorcardiovasculareventsaftercovid19eventratespostvaccinationantiviralorantiinflammatorytherapyandtemporaltrendscorrespondence AT wiwanitkitviroj majorcardiovasculareventsaftercovid19eventratespostvaccinationantiviralorantiinflammatorytherapyandtemporaltrendscorrespondence |